Genetic ablation of GLI2 or SMO in mice implies defective Hh signaling pathway that results in obesity, but, physiologically, whether dysregulated Hh signaling contributes to hypertrophic obesity warrants further investigation, in particular the missing link with ASCs and preadipocyte commitment [83]. The gene discussed is GLI2; the disease is obesity disorder.